08:04 AM EST, 12/20/2024 (MT Newswires) -- Aptose Biosciences ( APTO ) shares were up over 73% in recent Friday premarket activity, a day after the company said that the Nasdaq Hearings Panel approved its request for an extension to prove compliance with the minimum bid price requirement for continued listing on the Nasdaq.

Humacyte ( HUMA ) stock was 57% higher after the company said late Thursday that the US Food and Drug Administration granted full approval for SYMVESS, a bioengineered human tissue designed to be universally implantable.

Aadi Bioscience ( AADI ) shares were up 24% after the company said overnight it signed an exclusive license deal for a portfolio of preclinical antibody-drug conjugates and entered into deals that will raise up to $200 million.

FedEx ( FDX ) stock was up more than 7% after the company overnight posted higher fiscal Q2 adjusted earnings.